J L Harousseau1. Show Affiliations » 1. Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useBoronic Acids/therapeutic useBortezomibDisease-Free SurvivalDrug Therapy, CombinationHumansLenalidomideMultiple Myeloma/pathologyMultiple Myeloma/therapyPyrazines/therapeutic useRandomized Controlled Trials as TopicRemission Induction/methodsStem Cell TransplantationSurvival AnalysisThalidomide/analogs & derivativesThalidomide/therapeutic use
Substances: See more » Antineoplastic AgentsBoronic AcidsPyrazinesThalidomideBortezomibLenalidomide
Year: 2008 PMID: 18519405 DOI: 10.1093/annonc/mdn197
Source DB: PubMed Journal: Ann Oncol ISSN: 0923-7534 Impact factor: 32.976